2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain

Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., Waku, K.·1995·Biochemical and Biophysical Research Communications
DOI 10.1006/bbrc.1995.2437

Cited by (1,009)

Items 201–300 of 1,009

  1. Mechanisms of Endocannabinoid Inactivation: Biochemistry and Pharmacology
    Andrea Giuffrida, Massimiliano Beltramo, Daniele Piomelli · 2001 · Journal of Pharmacology and Experimental Therapeutics
  2. Anandamide: some like it hot
    Vincenzo Di Marzo, Tiziana Bisogno, Luciano De PETROCELLIS · 2001 · Trends in Pharmacological Sciences
  3. Control of the cell survival/death decision by cannabinoids
    Manuel Guzmán, Cristina Sánchez, Ismael Galve‐Roperh · 2000 · Journal of Molecular Medicine
  4. Endocannabinoids and β-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels
    Mario van der Stelt, Carmen Mazzola, Giuseppe Esposito, Isabel Matias, Stefania Petrosino, Daniele De Filippis, Vincenzo Micale, Luca Steardo, Filippo Drago, Teresa Iuvone et al. · 2006 · Cellular and Molecular Life Sciences
  5. 2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain
    Baggelaar, Marc P., Maccarrone, Mauro, van der Stelt, Mario · 2018 · Progress in Lipid Research
  6. Up‐regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation
    Giuseppe D’Argenio, Marta Valenti, Giuseppe Scaglione, Vittorio Cosenza, Italo Sorrentini, Vincenzo Di Marzo · 2006 · The FASEB Journal
  7. Retrograde signaling by endocannabinoids
    Anatol C. Kreitzer · 2002 · Current Opinion in Neurobiology
  8. DAGLβ inhibition perturbs a lipid network involved in macrophage inflammatory responses
    Hsu, Ku-Lung, Tsuboi, Katsunori, Adibekian, Alexander, Pugh, Holly, Masuda, Kim, Cravatt, Benjamin F · 2012 · Nature Chemical Biology
  9. N-Acylethanolamines and precursor phospholipids — relation to cell injury
    Harald Severin Hansen, Birthe Moesgaard, Henrik H. Hansen, Gitte Lindved Petersen · 2000 · Chemistry and Physics of Lipids
  10. Endocannabinoids and related N-acylethanolamines: biological activities and metabolism
    Kazuhito Tsuboi, Toru Uyama, Yasuo Okamoto, Natsuo Ueda · 2018 · Inflammation and Regeneration
  11. The synthetic cannabinoid WIN55,212‐2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain
    Daniel Bridges, Kamran Ahmad, Andrew S.C. Rice · 2001 · British Journal of Pharmacology
  12. Cannabinoid signaling in glial cells
    Nephi Stella · 2004 · Glia
  13. Aberrant cannabinoid signaling impairs oviductal transport of embryos
    Haibin Wang, Yong Xia Guo, Dingzhi Wang, Philip J. Kingsley, Lawrence J. Marnett, Sanjoy Das, Raymond N. DuBois, Sudhansu K. Dey · 2004 · Nature Medicine
  14. Endocannabinoids in the regulation of appetite and body weight
    Tim C. Kirkham · 2005 · Behavioural Pharmacology
  15. Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease
    Vincenzo Di Marzo · 2000 · The FASEB Journal
  16. Endocannabinoid signaling mediates oxytocin-driven social reward
    Wei, Don, Lee, DaYeon, Cox, Conor D., Karsten, Carley A., Peñagarikano, Olga, Geschwind, Daniel H., Gall, Christine M., Piomelli, Daniele · 2015 · Proceedings of the National Academy of Sciences
  17. Non-CB1, Non-CB2 Receptors for Endocannabinoids, Plant Cannabinoids, and Synthetic Cannabimimetics: Focus on G-protein-coupled Receptors and Transient Receptor Potential Channels
    Luciano De PETROCELLIS, Vincenzo Di Marzo · 2009 · Journal of Neuroimmune Pharmacology
  18. Cannabinoid CB1 and CB2 Receptor Signaling and Bias
    Mikkel Søes Ibsen, M. Connor, M. Glass · 2017 · Cannabis and Cannabinoid Research
  19. Marijuana and the Cannabinoids
    Mahmoud A. ElSohly · 2007 · Humana Press eBooks
  20. Anandamide, but not 2‐arachidonoylglycerol, accumulates during in vivo neurodegeneration
    Henrik H. Hansen, Patricia C. Schmid, Petra Bittigau, Isabel Lastres‐Becker, Fernando Berrendero, Jorge Manzanares, Chrysanthy Ikonomidou, Harald H.O. Schmid, J. Javier Fernández‐Ruiz, Harald Severin Hansen · 2001 · Journal of Neurochemistry
  21. Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors
    Sravan Kumar Goparaju, Natsuo Ueda, Kyoko Taniguchi, Shozo Yamamoto · 1999 · Biochemical Pharmacology
  22. Endocannabinoid Binding to the Cannabinoid Receptors: What Is Known and What Remains Unknown
    Patricia H. Reggio · 2010 · Current Medicinal Chemistry
  23. Endocannabinoid mechanisms of pain modulation
    Andrea G. Hohmann, Richard L. Suplita · 2006 · The AAPS Journal
  24. Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal
    Scavone, J.L., Sterling, R.C., Van Bockstaele, E.J. · 2013 · Neuroscience
  25. Regulation of endocannabinoid signaling by stress: Implications for stress-related affective disorders
    Gorzalka, Boris B., Hill, Matthew N., Hillard, Cecilia J. · 2008 · Neuroscience & Biobehavioral Reviews
  26. Endocannabinoid system in neurodegenerative disorders
    Balapal S. Basavarajappa, Madhu Shivakumar, Vikram Joshi, Shivakumar Subbanna · 2017 · Journal of Neurochemistry
  27. Transacylase‐Mediated and Phosphodiesterase‐Mediated Synthesis ofN‐Arachidonoylethanolamine, an Endogenous Cannabinoid‐Receptor Ligand, in Rat Brain Microsomes
    Takayuki Sugiura, Sachiko Kondo, Akihiro Sukagawa, Takashi Tonegawa, Shinji Nakane, Atsushi Yamashita, Yoshio Ishima, Keizo Waku · 1996 · European Journal of Biochemistry
  28. Anxiolytic Effects in Mice of a Dual Blocker of Fatty Acid Amide Hydrolase and Transient Receptor Potential Vanilloid Type-1 Channels
    Micale, Vincenzo, Cristino, Luigia, Tamburella, Alessandra, Petrosino, Stefania, Leggio, Gian Marco, Drago, Filippo, Di Marzo, Vincenzo · 2009 · Neuropsychopharmacology
  29. The Cellular Uptake of Anandamide Is Coupled to Its Breakdown by Fatty-acid Amide Hydrolase
    Dale G. Deutsch, Sherrye T. Glaser, Judy M. Howell, Jeffrey S. Kunz, Robyn A. Puffenbarger, Cecilia J. Hillard, Nada A. Abumrad · 2001 · Journal of Biological Chemistry
  30. Endocannabinoids and Synaptic Function in the CNS
    Yuki Hashimotodani, Takako Ohno‐Shosaku, Masanobu Kano · 2007 · The Neuroscientist
  31. The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression
    Pitsillou, Eleni, Bresnehan, Sarah M., Kagarakis, Evan A., Wijoyo, Stevano J., Liang, Julia, Hung, Andrew, Karagiannis, Tom C. · 2020 · Molecular Biology Reports
  32. Discovery and characterization of endogenous cannabinoids
    Billy R. Martin, Raphael Mechoulam, Raj K. Razdan · 1999 · Life Sciences
  33. Cellular accumulation of anandamide: consensus and controversy
    Cecilia J. Hillard, Abbas Jarrahian · 2003 · British Journal of Pharmacology
  34. The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling
    Joseph Tam, Victoria Trembovler, Vincenzo Di Marzo, Stefania Petrosino, Gabriella Leo, Alex Alexandrovich, Eran Regev, Nardy Casap, Arie Shteyer, Catherine A. Ledent et al. · 2007 · The FASEB Journal
  35. The endocannabinoid signalling system: Biochemical aspects
    Tiziana Bisogno, Alessia Ligresti, Vincenzo Di Marzo · 2005 · Pharmacology Biochemistry and Behavior
  36. A Lipid Pathway for Ligand Binding Is Necessary for a Cannabinoid G Protein-coupled Receptor
    Dow P. Hurst, Alan M. Grossfield, Diane L. Lynch, Scott E. Feller, Tod D. Romo, Klaus Gawrisch, Michael C. Pitman, Patricia H. Reggio · 2010 · Journal of Biological Chemistry
  37. European Pain Federation ( EFIC ) position paper on appropriate use of cannabis‐based medicines and medical cannabis for chronic pain management
    Winfried Häuser, David P. Finn, Eija Anneli Kalso, Nevenka Krcevski‐Škvarč, Hans Georg Kress, Bart J. Morlion, Serge Perrot, Michael Schäfer, Chris Wells, Silviu Brill · 2018 · European Journal of Pain
  38. The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide
    Vincenzo Di Marzo, Tiziana Bisogno, Takayuki SUGIURA, Dominique J. Melck, Luciano De PETROCELLIS · 1998 · Biochemical Journal
  39. Cyclooxygenase-2 in synaptic signaling
    Yang, Hongwei, Chen, Chu · 2008 · Current Pharmaceutical Design
  40. Therapeutic potential of monoacylglycerol lipase inhibitors
    Melinda M. Mulvihill, Daniel K. Nomura · 2012 · Life Sciences
  41. Endocannabinoids in liver disease
    Joseph Tam, Jie Liu, Bani Mukhopadhyay, Reşat Çınar, Grzegorz Godlewski, George Kunos · 2010 · Hepatology
  42. Endocannabinoid Dysregulation in the Pancreas and Adipose Tissue of Mice Fed With a High‐fat Diet
    Katarzyna Starowicz, Luigia Cristino, Isabel Matias, Raffaele Capasso, Alessandro Racioppi, Angelo Antonio Izzo, Vincenzo Di Marzo · 2008 · Obesity
  43. Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products
    Dongchen An, Steve Peigneur, Louise Antonia Hendrickx, Jan Tytgat · 2020 · International Journal of Molecular Sciences
  44. The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes
    Cecilia J. Hillard, Abbas Jarrahian · 2000 · Chemistry and Physics of Lipids
  45. Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease
    Sreemanti Basu, Bonnie N. Dittel · 2011 · Immunologic Research
  46. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection
    Evan C. Rosenberg, Pabitra Hriday Patra, Benjamin J. Whalley · 2017 · Epilepsy & Behavior
  47. Cannabinoids and Pain: Sites and Mechanisms of Action
    Katarzyna Starowicz, David P. Finn · 2017 · Advances in pharmacology
  48. Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression?
    Matthew N. Hill, Boris B. Gorzalka · 2005 · Behavioural Pharmacology
  49. Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target
    Tommaso Cassano, Silvio Calcagnini, Lorenzo Pace, Federico De Marco, Adele Romano, Silvana Gaetani · 2017 · Frontiers in Neuroscience
  50. Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders
    Sudhir M. Baswan, Allison E. Klosner, Kelly M. Glynn, Arun Rajgopal, Kausar A. Malik, Sunghan Yim, Nathan Stern · 2020 · Clinical Cosmetic and Investigational Dermatology
  51. Increased Seizure Susceptibility and Proconvulsant Activity of Anandamide in Mice Lacking Fatty Acid Amide Hydrolase
    Angela B. Clement, Edward G. Hawkins, Aron H. Lichtman, Benjamin F. Cravatt · 2003 · Journal of Neuroscience
  52. 15-Lipoxygenase Metabolism of 2-Arachidonylglycerol
    Kevin Robert Kozak, Rajnish A. Gupta, John S. Moody, Chuan Ji, William E. Boeglin, Raymond N. DuBois, ALAN R. BRASH, Lawrence J. Marnett · 2002 · Journal of Biological Chemistry
  53. N -arachidonoyl l -serine, an endocannabinoid-like brain constituent with vasodilatory properties
    Garry Milman, Yehoshua Maor, Saleh Abu‐Lafi, Michal Horowitz, Ruth Gallily, Sándor Bátkai, Fong-Ming Mo, László Offertáler, Pál Pacher, George Kunos et al. · 2006 · Proceedings of the National Academy of Sciences
  54. Exogenous Anandamide Protects Rat Brain against Acute Neuronal InjuryIn Vivo
    Mario van der Stelt, Wouter Bernard Veldhuis, Gijs W van Haaften, Filomena Fezza, Tiziana Bisogno, Peter R. Bär, Gerrit A. Veldink, Johannes F.G. Vliegenthart, Vincenzo Di Marzo, Klaas Nicolay · 2001 · Journal of Neuroscience
  55. Crystal Structure of the Human Monoacylglycerol Lipase, a Key Actor in Endocannabinoid Signaling
    Geoffray Labar, Cédric Bauvois, Franck Borel, Jean-Luc Ferrer, Johan Wouters, Didier M. Lambert · 2009 · ChemBioChem
  56. Tetrahydrocannabinol and endocannabinoids in feeding and appetite
    Elliot M. Berry, Raphael Mechoulam · 2002 · Pharmacology & Therapeutics
  57. Endocannabinoids in the central nervous system-an overview
    Ester Fride · 2002 · Prostaglandins Leukotrienes and Essential Fatty Acids
  58. Inhibitory effects of cannabinoid CB 1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis
    Giuseppe Portella, Chiara Laezza, Paolo Laccetti, Luciano De PETROCELLIS, Vincenzo Di Marzo, Maurizio Bifulco · 2003 · The FASEB Journal
  59. Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
    Maccarrone, Mauro, Di Marzo, Vincenzo, Gertsch, Jürg, Grether, Uwe, Howlett, Allyn C., Hua, Tian, Makriyannis, Alexandros, Piomelli, Daniele, Ueda, Natsuo, van der Stelt, Mario · 2023 · Pharmacological Reviews
  60. Biology of endocannabinoid synthesis system
    Jun Wang, Natsuo Ueda · 2008 · Prostaglandins & Other Lipid Mediators
  61. Endocannabinoids as physiological regulators of colonic propulsion in mice
    Luísa Pinto, Angelo Antonio Izzo, Nicola Mascolo, Francesco Capasso, Maria Grazia Cascio, Tiziana Bisogno, Vincenzo Di Marzo, Karen Hospodar–Scott, David R. Brown · 2002 · Gastroenterology
  62. Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors
    Antonia Serrano, Loren H. Parsons · 2011 · Pharmacology & Therapeutics
  63. Presence and regulation of the endocannabinoid system in human dendritic cells
    Isabel Matias, Pierre Pochard, Pierangelo Orlando, Michel Salzet, Joël Pestel, Vincenzo Di Marzo · 2002 · European Journal of Biochemistry
  64. CB cannabinoid receptor signalling in Parkinson’s disease
    Jonathan M. Brotchie · 2003 · Current Opinion in Pharmacology
  65. Endocannabinoid signalling: has it got rhythm?
    Vaughn, Linda K, Denning, Gerene, Stuhr, Kara L, de Wit, Harriet, Hill, Matthew N, Hillard, Cecilia J · 2010 · British Journal of Pharmacology
  66. Critical Enzymes Involved in Endocannabinoid Metabolism
    Balapal S. Basavarajappa · 2007 · Protein and Peptide Letters
  67. Endocannabinoids in the retina: From marijuana to neuroprotection
    Stephen Yazulla · 2008 · Progress in Retinal and Eye Research
  68. A Cannabinoid CB1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects
    Bogna Marta Ignatowska-Jankowska, Gemma L. Baillie, Steven G. Kinsey, Molly S. Crowe, Sudeshna Ghosh, Robert A Owens, Mohamad Imad Damaj, Justin L. Poklis, Jenny L. Wiley, Matteo Zanda et al. · 2015 · Neuropsychopharmacology
  69. Cannabinoids and anxiety
    Moreira, Fabrício A., Wotjak, Carsten T. · 2009 · Current topics in behavioral neurosciences
  70. Endocannabinoids, Related Compounds and Their Metabolic Routes
    Filomena Fezza, Monica Bari, Rita Florio, Emanuela Talamonti, Monica Feole, Mauro Maccarrone · 2014 · Molecules
  71. Cannabinoid analgesia
    Walker, J.Michael, Huang, Susan M · 2002 · Pharmacology & Therapeutics
  72. Cannabinoid Mechanisms of Pain Suppression
    J. M. Walker, Andrea G. Hohmann · 2005 · Handbook of experimental pharmacology
  73. Acetylene Group, Friend or Foe in Medicinal Chemistry
    Tanaji T. Talele · 2020 · Journal of Medicinal Chemistry
  74. Pharmacology of cannabinoids.
    Franjo Grotenhermen · 2004 · PubMed
  75. Beyond THC and Endocannabinoids
    Pacher, Pal, Kogan, Natalya M., Mechoulam, Raphael · 2020 · Annual Review of Pharmacology and Toxicology
  76. Arachidonoylserotonin and Other Novel Inhibitors of Fatty Acid Amide Hydrolase
    Tiziana Bisogno, Dominique J. Melck, Luciano De PETROCELLIS, М. Yu. Bobrov, Natalia M. Gretskaya, В. В. Безуглов, Namthip Sitachitta, William H. Gerwick, Vincenzo Di Marzo · 1998 · Biochemical and Biophysical Research Communications
  77. Metabolism of the Endocannabinoid Anandamide: Open Questions after 25 Years
    Mauro Maccarrone · 2017 · Frontiers in Molecular Neuroscience
  78. Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders
    Luciano De PETROCELLIS, Dominique J. Melck, Tiziana Bisogno, Vincenzo Di Marzo · 2000 · Chemistry and Physics of Lipids
  79. Cannabinoids and prefrontal cortical function: Insights from preclinical studies
    Alice Egerton, Claire Allison, Ros R. Brett, Judith A. Pratt · 2006 · Neuroscience & Biobehavioral Reviews
  80. The evolution and comparative neurobiology of endocannabinoid signalling
    Maurice R. Elphick · 2012 · Philosophical Transactions of the Royal Society B Biological Sciences
  81. Oxidative metabolism of endocannabinoids
    Kevin Robert Kozak, Lawrence J. Marnett · 2002 · Prostaglandins Leukotrienes and Essential Fatty Acids
  82. A Key Role for Diacylglycerol Lipase-α in Metabotropic Glutamate Receptor-Dependent Endocannabinoid Mobilization
    Kwang‐Mook Jung, Giuseppe Astarita, Chenggang Zhu, Matthew Wallace, Ken Mackie, Daniele Piomelli · 2007 · Molecular Pharmacology
  83. Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells
    Melck, Dominique, Rueda, Daniel, Galve-Roperh, Ismael, De Petrocellis, Luciano, Guzmán, Manuel, Di Marzo, Vincenzo · 1999 · FEBS Letters
  84. Plant, Synthetic, and Endogenous Cannabinoids in Medicine
    Vincenzo Di Marzo, Luciano De PETROCELLIS · 2005 · Annual Review of Medicine
  85. Endocannabinoids and traumatic brain injury
    Esther Shohami, Ayelet Cohen‐Yeshurun, Lital Magid, Merav Algali, Raphael Mechoulam · 2011 · British Journal of Pharmacology
  86. Structural Basis for Human Monoglyceride Lipase Inhibition
    Thomas Bertrand, Franck Augé, Jacques Houtmann, Alexey Rak, François Vallée, Vincent Mikol, Pierre‐François Berne, Nadine Michot, D. Cheuret, C. Hoornaert et al. · 2009 · Journal of Molecular Biology
  87. Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis
    Meir S Steiner, Carsten Tobias Wotjak · 2008 · Progress in brain research
  88. N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA)
    Natsuo Ueda, Kazuhito Tsuboi, Toru Uyama · 2010 · Progress in Lipid Research
  89. Targeting Fatty Acid Amide Hydrolase (FAAH) to Treat Pain and Inflammation
    Joel E. Schlosburg, Steven G. Kinsey, Aron H. Lichtman · 2009 · The AAPS Journal
  90. Endogenous Cannabinoids: Structure and Metabolism
    Tiziana Bisogno · 2008 · Journal of Neuroendocrinology
  91. Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes
    Susanna M. Saario, Juha R. Savinainen, Jarmo T. Laitinen, Tomi Järvinen, Riku Niemi · 2004 · Biochemical Pharmacology
  92. The expanding field of cannabimimetic and related lipid mediators
    Heather B. Bradshaw, James M. Walker · 2005 · British Journal of Pharmacology
  93. Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization
    Sonia Hernández‐Tiedra, Gemma Fabriàs, David Dávila, Íñigo J. Salanueva, Josefina Casas, Lidia Ruth Montes, Zuriñe Antón, Elena García-Taboada, María Salazar‐Roa, Mar Lorente et al. · 2016 · Autophagy
  94. Food for Mood: Relevance of Nutritional Omega-3 Fatty Acids for Depression and Anxiety
    Thomas Larrieu, Sophie Layé · 2018 · Frontiers in Physiology
  95. Phosphatidic Acid as the Biosynthetic Precursor of the Endocannabinoid 2‐Arachidonoylglycerol in Intact Mouse Neuroblastoma Cells Stimulated with Ionomycin
    Tiziana Bisogno, Dominique J. Melck, Luciano De PETROCELLIS, Vincenzo Di Marzo · 1999 · Journal of Neurochemistry
  96. Ligand-receptor signaling with endocannabinoids in preimplantation embryo development and implantation
    Bibhash C. Paria, Sudhansu K. Dey · 2000 · Chemistry and Physics of Lipids
  97. Cannabinoids in the treatment of glaucoma
    Tomi Järvinen, David W. Pate, Krista Laine · 2002 · Pharmacology & Therapeutics
  98. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: Effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment
    Guindon, Josée, Lai, Yvonne, Takacs, Sara M., Bradshaw, Heather B., Hohmann, Andrea G. · 2013 · Pharmacological Research
  99. The use of cannabinoids as anticancer agents
    Guillermo Velasco, Sonia Hernández‐Tiedra, David Dávila, Mar Lorente · 2015 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  100. Fatty acid amide signaling molecules
    Cyrine Ezzili, Katerina Otrubova, Dale L. Boger · 2010 · Bioorganic & Medicinal Chemistry Letters